Pharmacokinetics of High Dose Methotrexate : 1 : In Acute Renal Failure

T. Toyoguchi, H. Nagaoka, Shu Isikawa, Y. Nakagawa, Y. Izumi, Michihiko Katuura, Y. Okuyama, M. Okada, Tadashi Hayashi
{"title":"Pharmacokinetics of High Dose Methotrexate : 1 : In Acute Renal Failure","authors":"T. Toyoguchi, H. Nagaoka, Shu Isikawa, Y. Nakagawa, Y. Izumi, Michihiko Katuura, Y. Okuyama, M. Okada, Tadashi Hayashi","doi":"10.5649/jjphcs1975.16.94","DOIUrl":null,"url":null,"abstract":"Acute renal failure developed in a 5 year-old girl during the fifth course of high dose methotrexate (MTX) treatment for osteosarcoma. She showed oliguria, and the serum MTX concentration, BUN and Scr were 461 μmoles/1, 50 mg/dl and 2.6 mg/dl, respectively, at 27 hr after infusion.Massive leucovorin calcium rescure, direct hemoperfusion, hemodialysis and plasma exchange therapies were successfully treated and she recovered gradually.Neither toxic bone marrow suppression nor side effect of massive leucovorin calcium appeared.The pharmacokinetic analysis of MTX during the renal failure and the dialysis treatment was investigated.","PeriodicalId":17399,"journal":{"name":"Journal of the Nippon Hospital Pharmacists Association","volume":"23 1","pages":"94-100"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Nippon Hospital Pharmacists Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/jjphcs1975.16.94","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Acute renal failure developed in a 5 year-old girl during the fifth course of high dose methotrexate (MTX) treatment for osteosarcoma. She showed oliguria, and the serum MTX concentration, BUN and Scr were 461 μmoles/1, 50 mg/dl and 2.6 mg/dl, respectively, at 27 hr after infusion.Massive leucovorin calcium rescure, direct hemoperfusion, hemodialysis and plasma exchange therapies were successfully treated and she recovered gradually.Neither toxic bone marrow suppression nor side effect of massive leucovorin calcium appeared.The pharmacokinetic analysis of MTX during the renal failure and the dialysis treatment was investigated.
大剂量甲氨蝶呤的药代动力学:1:急性肾衰竭
急性肾衰竭发生在一个5岁的女孩在第5疗程的高剂量甲氨蝶呤(MTX)治疗骨肉瘤。患者出现少尿,输注后27小时血清MTX、BUN、Scr分别为461 μmol / 1,50 mg/dl、2.6 mg/dl。经大量亚钙素补钙、直接血液灌流、血液透析及血浆置换治疗成功,患者逐渐康复。未见骨髓毒性抑制和大量亚叶酸钙的副作用。研究了甲氨蝶呤在肾功能衰竭和透析治疗中的药代动力学分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信